Efficacy of rituximab in gastric diffuse large B cell lymphoma patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

357

HTML

2807

Figures (1-1)

141

Tables (1-4)

133

Sum=3438

May 28, 2010 (publication date) through May 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 28, 2010; 16(20): 2526-2530
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2526

Table 1 Lugano staging of GI lymphomas

Stage I: tumor confined to GI tract

Stage II: tumor extending into abdomen from GI site

II 1 = local nodal involvement

II 2 = distant nodal involvement

Stage III: penetration of serosa to involve adjacent organs or tissue

Stage IV: disseminated extranodal involvement, or supradiaphragmatic nodal involvement

GI: Gastrointestinal.

Citation: Leopardo D, Lorenzo GD, Renzo AD, Federico P, Luponio S, Buonerba C, Matano E, Merola G, Imbimbo M, Montesarchio E, Rea A, Merola MC, Placido SD, Palmieri G. Efficacy of rituximab in gastric diffuse large B cell lymphoma patients. World J Gastroenterol 2010; 16(20): 2526-2530
URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2526.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i20.2526